UK trial to assess mixed Covid-19 vaccine regimens in adolescents
Subjects will receive a first dose of the Pfizer-BioNTech vaccine and a second dose of...
News
Biogen reports positive Phase II data of non-opioid pain drug in SFN
Vixotrigine 200mg dose met the primary endpoint while 350mg failed to achieve the goal, with...
Boehringer Ingelheim and Amgen collaborate on cancer trial
The trial will evaluate the combination of BI 1701963 and Lumakras (sotorasib) in patients with...
FDA accepts Intellia Therapeutics’ application for leukaemia study
The study will evaluate the safety, tolerability, cell kinetics and anti-tumour activity of NTLA-5001 in...
FDA approves first trial investigating CRISPR gene editing as HIV cure
A new paradigm for HIV treatment is on the horizon as FDA gives nod for...
Meitheal reports positive data from anticoagulants trial for Covid-19
Therapeutic treatment with anticoagulants demonstrated similar outcomes in younger and older patients.
CinnaGen protein subunit Covid-19 vaccine Phase III results likely within two months
Race to be the first widely distributed protein subunit Covid-19 vaccine heats up with Vaxine nipping at Novavax’s heels.
Aerie’s dry eye therapeutic improves symptoms and signs in Phase IIb trial
A statistically significant improvement in symptoms and signs was observed at day 14 and sustained through day 84.
Russia’s Sputnik V vaccine shows 97.2% efficacy against Covid-19
According to real-world data from the Belarus Ministry of Health, the Sputnik V vaccine showed high safety profile against Covid-19.
Biophytis to continue Phase II/III Covid-19 drug trial without changes
According to interim analysis 2, the trial was in a promising zone and does not need modifications in sample size.
Syneos Health acquires StudyKIK to boost tech-enabled solutions offering
The deal complements Syneos’ acquisition of Illingworth Research Group and collaborations with Ride Health, Science37 and Medable.
